Skip to main content
Laurus Labs Limited logo

Laurus Labs Limited — Investor Relations & Filings

Ticker · LAURUSLABS ISIN · INE947Q01028 LEI · 335800S8HO8QRYP3VQ26 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2023-08-17 Regulatory Filings
Country IN India
Listing BSE.NS LAURUSLABS

About Laurus Labs Limited

https://www.lauruslabs.com/

Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of an analyst/institutional investor meeting. It references compliance with SEBI regulations and provides details of the meeting date and participants. There is no financial data, no detailed report, no voting results, no management changes, and no legal or capital structure updates. The document is brief (1534 characters) and serves as an announcement of an upcoming event rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-08-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of analyst and institutional investor meetings. It references compliance with SEBI Listing Obligations and Disclosure Requirements but does not contain any financial data, detailed report, or results. It is an announcement of a meeting schedule rather than a report or transcript. The document length is only 1525 characters, indicating it is a brief announcement. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-08-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of a Q1 FY24 earnings conference call held on July 27, 2023. It includes detailed management commentary on financial results, business updates, and a Q&A session. The text explicitly mentions it is a transcript of the earnings call, which is a full text record of the conference call. It contains no standalone financial statements or formal report filings but is a verbatim record of the call. Therefore, it fits the definition of a Call Transcript (CT). The document length is substantial (15,000 characters), indicating it is the full transcript, not just an announcement or summary.
2023-08-01 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges regarding the audio recording of the Q1 FY24 results conference call held on July 27, 2023. It references the conference call and provides a web link to the audio recording, but does not contain the transcript or detailed financial data itself. The document is only 1473 characters long, which is quite brief and consistent with an announcement rather than a full report. According to the rules, announcements about conference calls or their recordings are classified as Call Transcript (CT) only if the full transcript is provided. Since this is only an announcement of the audio recording, it does not qualify as a full Call Transcript. It is also not an Annual Report, Interim Report, or Earnings Release because it lacks substantive financial data. The best fitting category is Regulatory Filings (RNS), as it is a regulatory announcement related to disclosure obligations under SEBI regulations but does not contain the actual report or transcript itself.
2023-07-27 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release announcing the financial results for the quarter ended June 30, 2023 (Q1 FY24). It contains summarized financial highlights such as revenue, EBITDA, PAT, and EPS, along with management commentary and business segment performance. The document is not a full quarterly report with detailed financial statements or comprehensive analysis, but rather an initial announcement of quarterly financial results. It is not an earnings call transcript, annual report, or any other detailed report type. Therefore, the document fits the definition of an Earnings Release (ER). The document length (8878 characters) supports it being a detailed press release rather than a brief announcement or a full report. Q1 2024
2023-07-27 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Q1 FY 2024 Financial Results and Business Update' and is dated July 27, 2023. It contains detailed financial data for the quarter ended June 30, 2023, including revenues, EBITDA, net profit, segment performance, and business strategy. The document is a presentation intended for investors and analysts, as indicated by the heading 'Investors/Analysts Presentation' and references to an analyst call. The content includes forward-looking statements, financial metrics, business review, strategy, and outlook, which are typical components of an investor presentation. The document is not a full annual or interim report, nor is it a regulatory filing or announcement. Therefore, the most appropriate classification is Investor Presentation (IP). The document length (15,000 characters) and detailed financial and strategic content support this classification with high confidence.
2023-07-27 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.